1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
Check out our weekly earnings calendar and read the latest quarterly earnings previews.
Most people may not know it, but only a handful out of every thousand drugs that begin development ever make it to the final stages of trials – and not all of those are approved.
Markets have been so volatile this summer on U.S.-China trade tensions that investors might not have noticed: Tech stocks are absolutely red-hot in 2019.
Indeed, the technology sector of Standard...
More Investing News »